Answers are grounded in this paper and cite their sources.
• What is already known: • Validated behavioural tools, such as the Behavioural Pain Scale (BPS) and the Pain Indicator Behavioural Scale (ESCID), are commonly used to assess pain in non-communicative ICU patients. • However, there remains a lack of standardised protocols to guide pre-analgesia administration before painful procedures such as endotracheal aspiration (ETA). • What this paper adds • This randomised controlled trial will be the first to examine the efficacy of Pre-A monitoring by Pupillary Dilation Reflex (PDR) following calibrated stimuli in critically ill patients. • Using pupillometry to monitor analgesia could significantly improve individualised analgesia management before intervention. • This project may support the implementation of goal-directed analgesia protocols and contribute to improving overall care for critically ill patients. Effective pain management in sedated, mechanically ventilated patients is essential in intensive care, particularly before invasive procedures. The relationship between pain and biological stress is well established, but its manifestation depends on the patient's clinical state, calling for individualised and effective interventions. The Pupillary Dilation Reflex (PDR) has emerged as a potential objective tool for assessing nociceptive responses and guiding preemptive analgesia (Pre-A) before interventions. To evaluate the PDR as a physiological indicator of pain and its utility in guiding Pre-A before endotracheal aspiration (ETA) in sedated and ventilated ICU patients. We compare the incidence of pain, measured using PDR by video pupillometry, the Behavioural Pain Scale (BPS), and the Pain Indicator Behavioural Scale (ESCID), as well as the proportion of patients receiving Pre-A, between a pupillometry-guided group and a control group receiving standard care. In this multicenter, randomised controlled study, 82 critically ill, sedated patients with an estimated 10% oversampling to compensate for possible attrition will be enrolled and randomised (1:1) into intervention or control groups. In the intervention group, PDR will be measured after a 20 mA stimulus. Patients exhibiting a PDR ≥ 11.5%, a threshold indicating insufficient analgesia, as determined in precursor study (López de Audícana-Jimenez de Aberasturi Y et al., 2024a), will receive Pre-A according to established ICU protocols. The control group will receive Pre-A based on routine clinical assessment. Pain will be assessed using PDR by video pupillometry and behavioural pain scales (BPS and ESCID) after ETA by blinded researchers. Only the pupillometry researcher will be aware of the Pre-A decision. Group differences will be analysed using Chi-square and bivariate statistical methods to explore associations between pain and related clinical variables. The primary outcome will be post-intervention pain, assessed by pupillometry as well as BPS and ESCID scale scores. The second outcome will be the proportion of patients requiring Pre-A in the groups. Pupillometry-guided analgesia may offer a simple and effective bedside method for individualised pain management in sedated, mechanically ventilated ICU patients, potentially reducing pain-related complications. Phase 2 of the project PUPIPAIN ClinicalTrials.gov Identifier: NCT04078113
No takes yet. Share an insight, caveat, or question.
Aberasturi et al. (2025) studied this question.
Synapse has enriched 10 related papers. Consider them for comparative context: